Enlightened Experimentation: The New Imperative for Innovation;
Stefan Thomke; Harvard Business Review, Feb. 2001, pp. 67-75.
This article, by a Harvard Business School associate professor of
technology and operations management, contends that because new
technologies are making it
easier than ever to conduct complex
experiments cheaply and quickly, companies need to completely rethink
the way they conduct their R&D. Stefan Thomke argues that
"enlightened experimentation" affects everything, from the
development process itself--including the way an R&D organization is
structured--to how new knowledge is created. Consequently, companies
trying to be more innovative face managerial as well as technical
challenges. Drawing on his research in the pharmaceutical, automotive
and software industries, Thomke introduces four rules for enlightened
experimentation: organize for rapid experimentation; fail early and
often, but avoid mistakes; anticipate and exploit early information; and
combine new and old technologies.
His article uses examples from Millennium Pharmaceuticals, BMW,
IDEO, 3M, Toyota, and Eli Lilly to explain each rule. It also suggests
how this system of experimentation will affect other industries and
examines the implications for knowledge workers.